Elizabeth Renaud

ORCID: 0000-0002-7919-8229 · 1 paper in corpus
article 2004
Endometrial cancer expresses the Mullerian Inhibiting Substance (MIS) type II receptor and is growth inhibited by MIS
·doi:10.1016/j.jamcollsurg.2004.06.001

Renaud, Elizabeth J. MD; Oliva, Esther MD; Rueda, Bo PhD; MacLaughlin, David PhD; Donahoe, Patricia MD Author Information